Can I use Prostat AWC (Prostate Support Supplement) liquid to treat hypoalbuminemia (low albumin levels) and hypoproteinemia (low protein levels)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

No, you should not use Prostat AWC (a prostate support supplement) to treat hypoalbuminemia or hypoproteinemia. These conditions require medical evaluation and appropriate clinical treatment under healthcare supervision. Prostat AWC is formulated specifically for prostate health support, not for treating protein or albumin deficiencies in the blood. Low protein and albumin levels can indicate serious underlying medical conditions such as liver disease, kidney disease, malnutrition, or other health issues that need proper diagnosis and targeted treatment. The appropriate treatment typically involves addressing the underlying cause and may include dietary changes with increased protein intake, medical nutrition therapy, or in severe cases, albumin infusions 1. According to the clinical practice guidelines for nutrition in chronic renal failure, a protein intake of 1.2 g/kg/d and 1.3 g/kg/d is recommended for MHD and CPD patients, respectively 1. Prostate supplements contain ingredients like saw palmetto, beta-sitosterol, and plant extracts that have no proven effect on blood protein levels. If you're experiencing symptoms of low protein or albumin, consult with a healthcare provider immediately for proper testing, diagnosis, and an appropriate treatment plan. Some key points to consider in the management of hypoalbuminemia and hypoproteinemia include:

  • Monitoring serum albumin concentration on a regular basis and aiming for a stable or rising value 1
  • Evaluating serum albumin levels in the context of the patient’s overall clinical status, including comorbid diseases and quality-of-life issues 1
  • Providing adequate nutrition, preventing and treating catabolic illness, and maintaining optimal dialysis dose 1

From the FDA Drug Label

There is no information about Prostat AWC (Prostate Support Supplement) liquid in the provided drug labels.

The FDA drug label does not answer the question.

From the Research

Prostat AWC Liquid and Hypoalbuminemia/Hypoproteinemia

  • There is no direct evidence to suggest that Prostat AWC (Prostate Support Supplement) liquid can be used to treat hypoalbuminemia (low albumin levels) and hypoproteinemia (low protein levels) 2, 3, 4, 5, 6.
  • Hypoalbuminemia is a condition characterized by low levels of albumin in the blood, which can be caused by various factors such as inflammation, malnutrition, and liver or kidney disease 3, 4, 5.
  • The management of hypoalbuminemia should be based on correcting the underlying causes of inflammation and nutritional deficiencies, rather than relying on albumin infusion or supplements 3, 4.
  • Protein balance disorders, auxin resistance, and hyperleptinemia are key steps in the development of cirrhosis and hypoproteinemia, and treating these conditions requires a comprehensive approach that addresses the underlying pathogenic mechanisms 5.
  • C-reactive protein and low albumin are predictors of morbidity and cardiovascular events in chronic kidney disease patients, highlighting the importance of monitoring and managing these conditions to prevent adverse outcomes 6.

Treatment of Hypoalbuminemia and Hypoproteinemia

  • The treatment of hypoalbuminemia and hypoproteinemia should focus on addressing the underlying causes of these conditions, such as inflammation, malnutrition, and liver or kidney disease 3, 4, 5.
  • Nutrition support, including adequate protein and calorie intake, can help to slow down the progression of muscle mass and function loss, especially when combined with physical exercise 3.
  • In some cases, albumin infusion may be necessary to increase intravascular oncotic pressure and mobilize edema fluid, but this should be done under the guidance of a healthcare professional and as part of a comprehensive treatment plan 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Slipping Through the Pores: Hypoalbuminemia and Albumin Loss During Hemodialysis.

International journal of nephrology and renovascular disease, 2021

Research

Hypoalbuminemia: Pathogenesis and Clinical Significance.

JPEN. Journal of parenteral and enteral nutrition, 2019

Research

Research Progress and Treatment Status of Liver Cirrhosis with Hypoproteinemia.

Evidence-based complementary and alternative medicine : eCAM, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.